Celebrating 25 Years of Scoop
Special: Up To 25% Off Scoop Pro Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Bio-Strategy secures key distributorship

17 December 2004

Bio-Strategy secures key distributorship

Bio-Strategy Distribution has been appointed distributor of Pall Laboratory Products in New Zealand, effective 1 January, 2005.

Pall New Zealand Limited is the local arm of global company Pall Corporation. Pall's business is organized around two broad markets: Life Sciences and Industrial. The company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, semiconductor, water purification, aerospace and broad industrial markets. Globally the corporation has annual sales exceeding $US1.77 billion and invests approximately 10 percent each year into R&D.

Bio-Strategy Managing Director Earl Stevens says this deal is another key opportunity for the company to assist in developing the New Zealand biotech industry.

“It is exciting to watch the growing breadth and depth of agencies we represent. Pall is held in extremely high esteem and is at home amongst our portfolio of specialist biotech industry goods and consumables suppliers. Pall prizes innovation and the highest quality standards and is therefore consistent with our mission of developing New Zealand’s biotech industry capability.”

This deal follows hard on the heels of September’s announcement that Bio-Strategy had been appointed a distributor for Merck.

“While still a relatively new distribution company, there is considerable industry experience guiding it, which has provided the credibility necessary to attract quality agencies seeking a new distribution partner.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

“Our strength comes from linking our biotech and international business experience and expertise with an understanding of what our customers are seeking from laboratory products, consumables and apparatus. With our in-depth knowledge of the industry, we can add value to customers’ purchase decisions.”

Pall New Zealand Limited Managing Director Les Brown says the decision to realign their distribution with Bio-Strategy was based on the company’s marketing focus and demonstrated customer service ability.

“I was impressed with Bio-Strategy’s operation, and could see advantages for Pall to tap into Bio-Strategy’s marketing capability and added-value approach. We believe our customers will receive the best service on offer, and appreciate the advantages that Bio-Strategy Distribution brings.”

Pall filtration and separation equipment is used to develop and manufacture goods across a vast range of industries such as food and beverage, medical, fuels and chemicals, graphic arts, microelectronics, hydraulics and dairy.

A transition period from 1 December will ensure Bio-Strategy a smooth path into the distribution role so Pall customers are not disadvantaged during the hand over from the previous distributor.


© Scoop Media

Advertisement - scroll to continue reading
Business Headlines | Sci-Tech Headlines


Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.